The Diagnostic Assessment of Canine Lymphoma: Implications for Treatment

Clinics in Laboratory Medicine

Volumn 31, Issue 1, 2011, Pages 21-39

  Bienzle, Dorothee ^a   Vernau, William ^b  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clonal antigen receptor polymerase chain reaction; Flow cytometry; Immunohistochemistry; Lymphosarcoma; Veterinary; WHO classification

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; DOXORUBICIN; LYMPHOCYTE ANTIGEN RECEPTOR; PREDNISONE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN DETECTION; B CELL LYMPHOMA; BONE MARROW TRANSPLANTATION; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; DISEASE CLASSIFICATION; DOG; FLOW CYTOMETRY; FOLLICULAR LYMPHOMA; GENETIC PREDISPOSITION; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMA; MULTIMODALITY CANCER THERAPY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; T CELL LYMPHOMA; TREATMENT PLANNING;

ANIMALS; DOG DISEASES; DOGS; LYMPHOMA; PROGNOSIS;

EID: 79551485520     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2010.10.001     Document Type: Review

References (81)

1. Gamlem H., Nordstoga K., Glattre E. Canine neoplasia-introductory paper. APMIS Suppl 2008, 125:5-18.
2. Edwards D.S., Henley W.E., Harding E.F., et al. Breed incidence of lymphoma in a UK population of insured dogs. Vet Comp Oncol 2003, 1:200-206.
3. Dorn C.R., Taylor D.O., Schneider R. The epidemiology of canine leukemia and lymphoma. Bibl Haematol 1970, 36:403-415.
4. Teske E., Wisman P., Moore P.F., et al. Histologic classification and immunophenotyping of canine non-Hodgkin's lymphomas: unexpected high frequency of T cell lymphomas with B cell morphology. Exp Hematol 1994, 22:1179-1187.
5. Modiano J.F., Breen M., Burnett R.C., et al. Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk. Cancer Res 2005, 65:5654-5661.
6. Pastor M., Chalvet-Monfray K., Marchal T., et al. Genetic and environmental risk indicators in canine non-Hodgkin's lymphomas: breed associations and geographic distribution of 608 cases diagnosed throughout France over 1 year. J Vet Intern Med 2009, 23:301-310.
7. Modiano J.F., Breen M., Valli V.E., et al. Predictive value of p16 or Rb inactivation in a model of naturally occurring canine non-Hodgkin's lymphoma. Leukemia 2007, 21:184-187.
8. Moore P.F., Affolter V.K., Graham P.S., et al. Canine epitheliotropic cutaneous T-cell lymphoma: an investigation of T-cell receptor immunophenotype, lesion topography and molecular clonality. Vet Dermatol 2009, 20:569-576.
9. Fontaine J., Bovens C., Bettenay S., et al. Canine cutaneous epitheliotropic T-cell lymphoma: a review. Vet Comp Oncol 2009, 7:1-14.
10. Day M.J. Review of thymic pathology in 30 cats and 36 dogs. J Small Anim Pract 1997, 38:393-403.
11. Breen M., Modiano J.F. Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans-man and his best friend share more than companionship. Chromosome Res 2008, 16:145-154.
12. Hayes H.M., Tarone R.E., Cantor K.P. On the association between canine malignant lymphoma and opportunity for exposure to 2,4-dichlorophenoxyacetic acid. Environ Res 1995, 70:119-125.
13. Gavazza A., Presciuttini S., Barale R., et al. Association between canine malignant lymphoma, living in industrial areas, and use of chemicals by dog owners. J Vet Intern Med 2001, 15:190-195.
14. Garabrant D.H., Philbert M.A. Review of 2,4-dichlorophenoxyacetic acid (2,4-D) epidemiology and toxicology. Crit Rev Toxicol 2002, 32:233-257.
15. Ponce F., Marchal T., Magnol J.P., et al. A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology. Vet Pathol 2010, 47:414-433.
16. Greenlee P.G., Filippa D.A., Quimby F.W., et al. Lymphomas in dogs. A morphologic, immunologic, and clinical study. Cancer 1990, 66:480-490.
17. Fournel-Fleury C., Ponce F., Felman P., et al. Canine T-cell lymphomas: a morphological, immunological, and clinical study of 46 new cases. Vet Pathol 2002, 39:92-109.
18. Lurie D.M., Milner R.J., Suter S.E., et al. Immunophenotypic and cytomorphologic subclassification of T-cell lymphoma in the boxer breed. Vet Immunol Immunopathol 2008, 125:102-110.
19. Lurie D.M., Lucroy M.D., Griffey S.M., et al. T-cell-derived malignant lymphoma in the boxer breed. Vet Comp Oncol 2004, 2:171-175.
20. Thomas R., Smith K.C., Ostrander E.A., et al. Chromosome aberrations in canine multicentric lymphomas detected with comparative genomic hybridisation and a panel of single locus probes. Br J Cancer 2003, 89:1530-1537.
21. Fosmire S.P., Thomas R., Jubala C.M., et al. Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma. Vet Pathol 2007, 44:467-478.
22. Mortarino M., Gioia G., Gelain M.E., et al. Identification of suitable endogenous controls and differentially expressed microRNAs in canine fresh-frozen and FFPE lymphoma samples. Leuk Res 2010, 34:1070-1077.
23. Teske E., van Heerde P. Diagnostic value and reproducibility of fine-needle aspiration cytology in canine malignant lymphoma. Vet Q 1996, 18:112-115.
24. Caniatti M., Roccabianca P., Scanziani E., et al. Canine lymphoma: immunocytochemical analysis of fine-needle aspiration biopsy. Vet Pathol 1996, 33:204-212.
25. Aulbach A.D., Swenson C.L., Kiupel M. Optimized processing of fine-needle lymph node biopsies for automated immunostaining. J Vet Diagn Invest 2010, 22:383-388.
26. Gibson D., Aubert I., Woods J.P., et al. Flow cytometric immunophenotype of canine lymph node aspirates. J Vet Intern Med 2004, 18:710-717.
27. Sözmen M., Tasca S., Carli E., et al. Use of fine needle aspirates and flow cytometry for the diagnosis, classification, and immunophenotyping of canine lymphomas. J Vet Diagn Invest 2005, 17:323-330.
28. Gentilini F., Turba M.E., Calzolari C., et al. Real-time quantitative PCR using hairpin-shaped clone-specific primers for minimal residual disease assessment in an animal model of human non-Hodgkin lymphoma. Mol Cell Probes 2010, 24:6-14.
29. Burnett R.C., Vernau W., Modiano J.F., et al. Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes. Vet Pathol 2003, 40:32-41.
30. Starkey M.P., Murphy S. Using lymph node fine needle aspirates for gene expression profiling of canine lymphoma. Vet Comp Oncol 2010, 8:56-71.
31. Valli V.E., Vernau W., de Lorimier L.P., et al. Canine indolent nodular lymphoma. Vet Pathol 2006, 43:241-256.
32. Valli V.E., Myint M.S., Barthel A., et al. Classification of canine malignant lymphoma according to the World Health Organization Criteria. Vet Pathol 2010, [Epub ahead of print].
33. Fournel-Fleury C., Magnol J.P., Bricaire P., et al. Cytohistological and immunological classification of canine malignant lymphomas: comparison with human non-Hodgkin's lymphomas. J Comp Pathol 1997, 117:35-59.
34. Jubala C.M., Wojcieszyn J.W., Valli V.E., et al. CD20 expression in normal canine B cells and in canine non-Hodgkin lymphoma. Vet Pathol 2005, 42:468-476.
35. Ponce F., Magnol J.P., Marchal T., et al. High-grade canine T-cell lymphoma/leukemia with plasmacytoid morphology: a clinical pathological study of nine cases. J Vet Diagn Invest 2003, 15:330-337.
36. Jaffe E.S., Harris N.L., Stein H., et al. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood 2008, 112:4384-4399.
37. Sitnikova T., Su C. Coevolution of immunoglobulin heavy- and light-chain variable-region gene families. Mol Biol Evol 1998, 15:617-625.
38. Aquino S.M., Hamor R.E., Valli V.E., et al. Progression of an orbital T-cell rich B-cell lymphoma to a B-cell lymphoma in a dog. Vet Pathol 2000, 37:465-469.
39. Vezzali E., Parodi A.L., Marcato P.S., et al. Histopathologic classification of 171 cases of canine and feline non-Hodgkin lymphoma according to the WHO. Vet Comp Oncol 2010, 8:38-49.
40. Day M.J. Immunophenotypic characterization of cutaneous lymphoid neoplasia in the dog and cat. J Comp Pathol 1995, 112:79-96.
41. McDonough S.P., Van Winkle T.J., Valentine B.A., et al. Clinicopathological and immunophenotypical features of canine intravascular lymphoma (malignant angioendotheliomatosis). J Comp Pathol 2002, 126:277-288.
42. Guija de Arespacochaga A., Schwendenwein I., Weissenböck H. Retrospective study of 82 cases of canine lymphoma in Austria based on the working formulation and immunophenotyping. J Comp Pathol 2007, 136:186-192.
43. Frank J.D., Reimer S.B., Kass P.H., et al. Clinical outcomes of 30 cases (1997-2004) of canine gastrointestinal lymphoma. J Am Anim Hosp Assoc 2007, 43:313-321.
44. Vascellari M., Multari D., Mutinelli F. Unicentric extranodal lymphoma of the upper eyelid conjunctiva in a dog. Vet Ophthalmol 2005, 8:67-70.
45. Kessler M., Kandel-Tschiederer B., Pfleghaar S., et al. Primary malignant lymphoma of the urinary bladder in a dog: longterm remission following treatment with radiation and chemotherapy. Schweiz Arch Tierheilkd 2008, 150:565-569.
46. Tasca S., Carli E., Caldin M., et al. Hematologic abnormalities and flow cytometric immunophenotyping results in dogs with hematopoietic neoplasia: 210 cases (2002-2006). Vet Clin Pathol 2009, 38:2-12.
47. Williams M.J., Avery A.C., Lana S.E., et al. Canine lymphoproliferative disease characterized by lymphocytosis: immunophenotypic markers of prognosis. J Vet Intern Med 2008, 22:596-601.
48. Vernau W., Moore P.F. An immunophenotypic study of canine leukemias and preliminary assessment of clonality by polymerase chain reaction. Vet Immunol Immunopathol 1999, 69:145-164.
49. Workman H.C., Vernau W. Chronic lymphocytic leukemia in dogs and cats: the veterinary perspective. Vet Clin North Am Small Anim Pract 2003, 33:1379-1399. viii.
50. Ramos-Vara J.A., Miller M.A., Valli V.E. Immunohistochemical detection of multiple myeloma 1/interferon regulatory factor 4 (MUM1/IRF-4) in canine plasmacytoma: comparison with CD79a and CD20. Vet Pathol 2007, 44:875-884.
51. Giraudel J.M., Pagès J.P., Guelfi J.F. Monoclonal gammopathies in the dog: a retrospective study of 18 cases (1986-1999) and literature review. J Am Anim Hosp Assoc 2002, 38:135-147.
52. Moore P.F., Olivry T., Naydan D. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8 + T cells. Am J Pathol 1994, 144:421-429.
53. Affolter V.K., Gross T.L., Moore P.F. Indolent cutaneous T-cell lymphoma presenting as cutaneous lymphocytosis in dogs. Vet Dermatol 2009, 20:577-585.
54. Fry M.M., Vernau W., Pesavento P.A., et al. Hepatosplenic lymphoma in a dog. Vet Pathol 2003, 40:556-562.
55. Cienava E.A., Barnhart K.F., Brown R., et al. Morphologic, immunohistochemical, and molecular characterization of hepatosplenic T-cell lymphoma in a dog. Vet Clin Pathol 2004, 33:105-110.
56. Comazzi S., Gelain M.E. Use of flow cytometric immunophenotyping to refine the cytological diagnosis of canine lymphoma. Vet J 2010, [Epub ahead of print].
57. Allison R.W., Brunker J.D., Breshears M.A., et al. Dendritic cell leukemia in a Golden Retriever. Vet Clin Pathol 2008, 37:190-197.
58. Weiss L.M., Spagnolo D.V. Assessment of clonality in lymphoid proliferations. Am J Pathol 1993, 142:1679-1682.
59. Griesser H., Tkachuk D., Reis M.D., et al. Gene rearrangements and translocations in lymphoproliferative diseases. Blood 1989, 73:1402-1415.
60. Knowles D.M. Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia. Am J Pathol 1989, 134:761-785.
61. Dreitz M.J., Ogilvie G., Sim G.K. Rearranged T lymphocyte antigen receptor genes as markers of malignant T cells. Vet Immunol Immunopathol 1999, 69:113-119.
62. Yamazaki J., Takahashi M., Setoguchi A., et al. Monitoring of minimal residual disease (MRD) after multidrug chemotherapy and its correlation to outcome in dogs with lymphoma: a proof-of-concept pilot study. J Vet Intern Med 2010, 24:897-903.
63. van Dongen J.J., Langerak A.W., Brüggemann M., et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003, 17:2257-2317.
64. Werner J.A., Woo J.C., Vernau W., et al. Characterization of feline immunoglobulin heavy chain variable region genes for the molecular diagnosis of B-cell neoplasia. Vet Pathol 2005, 42:596-607.
65. Greiner T.C., Raffeld M., Lutz C., et al. Analysis of T cell receptor-gamma gene rearrangements by denaturing gradient gel electrophoresis of GC-clamped polymerase chain reaction products. Correlation with tumor-specific sequences. Am J Pathol 1995, 146:46-55.
66. Davis T.H., Yockey C.E., Balk S.P. Detection of clonal immunoglobulin gene rearrangements by polymerase chain reaction amplification and single-strand conformational polymorphism analysis. Am J Pathol 1993, 142:1841-1847.
67. Signoretti S., Murphy M., Cangi M.G., et al. Detection of clonal T-cell receptor gamma gene rearrangements in paraffin-embedded tissue by polymerase chain reaction and nonradioactive single-strand conformational polymorphism analysis. Am J Pathol 1999, 154:67-75.
68. Langerak A.W., Szczepański T., van der Burg M., et al. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia 1997, 11:2192-2199.
69. Kneba M., Bolz I., Linke B., et al. Analysis of rearranged T-cell receptor beta-chain genes by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR fragment analysis. Blood 1995, 86:3930-3937.
70. Elenitoba-Johnson K.S., Bohling S.D., Mitchell R.S., et al. PCR analysis of the immunoglobulin heavy chain gene in polyclonal processes can yield pseudoclonal bands as an artifact of low B cell number. J Mol Diagn 2000, 2:92-96.
71. Hoeve M.A., Krol A.D., Philippo K., et al. Limitations of clonality analysis of B cell proliferations using CDR3 polymerase chain reaction. Mol Pathol 2000, 53:194-200.
72. Szczepański T., Beishuizen A., Pongers-Willemse M.J., et al. Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease. Leukemia 1999, 13:196-205.
73. Pelicci P.G., Knowles D.M., Dalla Favera R. Lymphoid tumors displaying rearrangements of both immunoglobulin and T cell receptor genes. J Exp Med 1985, 162:1015-1024.
74. Cheng G.Y., Minden M.D., Toyonaga B., et al. T cell receptor and immunoglobulin gene rearrangements in acute myeloblastic leukemia. J Exp Med 1986, 163:414-424.
75. Kyoda K., Nakamura S., Matano S., et al. Prognostic significance of immunoglobulin heavy chain gene rearrangement in patients with acute myelogenous leukemia. Leukemia 1997, 11:803-806.
76. Rovigatti U., Mirro J., Kitchingman G., et al. Heavy chain immunoglobulin gene rearrangement in acute nonlymphocytic leukemia. Blood 1984, 63:1023-1027.
77. Vail D.M., Michels G.M., Khanna C., et al. Veterinary Cooperative Oncology Group. Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)-a Veterinary Cooperative Oncology Group (VCOG) consensus document. Vet Comp Oncol 2010, 8:28-37.
78. Ettinger S.N. Principles of treatment for canine lymphoma. Clin Tech Small Anim Pract 2003, 18:92-97.
79. Chun R. Lymphoma: which chemotherapy protocol and why?. Top Companion Anim Med 2009, 24:157-162.
80. Marconato L. The staging and treatment of multicentric high-grade lymphoma in dogs: a review of recent developments and future prospects. Vet J 2010, [Epub ahead of print].
81. Lurie D.M., Gordon I.K., Théon A.P., et al. Sequential low-dose rate half-body irradiation and chemotherapy for the treatment of canine multicentric lymphoma. J Vet Intern Med 2009, 23:1064-1070.